Injective Labs

Injective Labs

Blockchain platform for decentralized finance applications

About Injective Labs

Simplify's Rating
Why Injective Labs is rated
A
Rated A on Competitive Edge
Rated A on Growth Potential
Rated A on Differentiation

Industries

Crypto & Web3

Financial Services

Company Size

51-200

Company Stage

N/A

Total Funding

$206.7M

Headquarters

New York City, New York

Founded

2018

Overview

Injective Labs focuses on developing a blockchain platform called Injective, which is tailored for financial applications. The platform allows users to trade in a decentralized manner, providing tools for developers in decentralized finance (DeFi) such as software development kits and Web3 modules. Injective incorporates auto-executing smart contracts that facilitate various applications, including on-chain finance and decentralized artificial intelligence. A key feature of Injective is its zero gas fees, ensuring secure and fast transactions, which enhances scalability for users. Founded in 2018, Injective Labs stands out by offering comprehensive blockchain development services and was part of Binance Labs' first incubation program.

Simplify Jobs

Simplify's Take

What believers are saying

  • Integration of AI in DeFi enhances trading strategies and risk management.
  • Cross-chain DeFi solutions enable seamless asset transfers across blockchain networks.
  • Layer 2 scaling solutions address scalability issues, improving platform performance.

What critics are saying

  • Increased competition from Binance Smart Chain and Polygon affects Injective's market share.
  • Security risks and vulnerabilities could impact user trust and platform reputation.
  • Limited liquidity may hinder Injective's ability to attract and retain users.

What makes Injective Labs unique

  • Injective Labs offers zero gas fees, enhancing cost-efficiency for users.
  • The platform supports auto-executing smart contracts for diverse financial applications.
  • Injective provides a decentralized trading experience with rapid transaction speeds.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$206.7M

Above

Industry Average

Funded Over

0 Rounds

Benefits

Health Insurance

Unlimited Paid Time Off

Flexible Work Hours

Hybrid Work Options

Company News

Crowdfund Insider
Oct 29th, 2023
Injective Defi Report: Majority Of Crypto Trading Activity Focused On Long-Term Holding Strategy

Injective, the blockchain built for finance, published its DeFi Trader Survey 2023.The research draws from various cryptocurrency trading communities, “aiming to provide a comprehensive understanding of how professionals and amateurs approach cryptocurrency trading, their motivations, and valuable lessons for the wider trading community.”Most respondents (63.8%) trade on “both a centralized and decentralized exchange. 14.7% trade only on centralized exchanges, and 11.2% trade only on decentralized exchanges.”Surprisingly, 10.3% of people “weren’t able to discern the types of exchanges.”For 62.1% of respondents Incentives provided by DeFi projects is the main factor “that influenced them to engage in DeFi trading.” The remaining main factors “include Potential for high returns (59.8%) and Access to a wide range of tokens (52.1%).”Most respondents (41%) consider Liquidity as “the primary factor that influenced which DEX they’ve chosen to trade on, followed by Trading Fees (38%) and Security Measures, Privacy, and Anonymity (29%).”Most respondents (55%) highlighted Security risks and vulnerabilities as “the main challenges they have encountered in DeFi trading, followed by Transaction speed and network congestion (54%), and Limited liquidity (46%).”For 37.3% of respondents trading is their main source of income, and “an additional one for 62.7% of them. 30.3% have 26-50% of their overall investment portfolio allocated to DeFi trading, followed by 29.3% of respondents with 11-25% of their portfolio allocated.”Most respondents (71%) usually prefer to “trade on Binance Smart Chain and Polygon (62%), followed by Ethereum (52%) and Injective (51%). Remaning blockchains include Solana (23%), Avalanche (15%), Fantom (8%), Polkadot (4%), and Cardano (2%).”Eric Chen, Co-founder, and CEO at Injective Labs, said:“While DeFi has experienced massive growth in the past few years, we have to continue to tackle issues such as scalability and liquidity. Traders are understanding the benefits of this technology, and we’re supporting their transition.”Multiple options for tradingIn addition to trading possibly on the traditional financial markets, traders in crypto utilize other strategies and “leverage rewards provided by protocols to improve their returns.”Most respondents (64%) highlighted HODLing (long-term holding) “as their preferred strategy when it comes to DeFi trading, followed by Yield farming (40%), and Day trading (32%). Other strategies included Swing trading and Liquidity provision both at 29%, Position trading (28%), Arbitrage (16%), and Market making (9%).”In recent years, the cryptocurrency market has “attracted a diverse range of participants, from seasoned financial professionals to enthusiastic amateurs, due to its volatility and profit potential.”Experienced professionals in the cryptocurrency community “leverage their financial market expertise, including technical analysis, risk management, and trend interpretation, to navigate the complex landscape of digital currencies.”Conversely, the rise of amateur traders in the cryptocurrency sphere is “driven by curiosity, quick gains, and a desire to engage in technological innovation.”Despite lacking formal financial education, these traders “are eager to adapt and embrace the fast-paced nature of crypto markets.”

AZCoin News
Jun 23rd, 2023
Injective (INJ) has launched early access to its DeFi platform Mito

Injective Labs, a leading Web3 project, has announced the launch of Mito, an innovative protocol that is set to revolutionize automated trading and yield generation.

FF News
Sep 2nd, 2022
Helix Launches On Injective To Bring Crypto To The Masses

Injective Pro, a decentralized derivatives exchange, has announced a rebrand to “Helix” while also introducing a wide array of new features and advanced trading capabilities. Helix launches in pursuit of bringing a premier decentralized trading experience to the masses. Helix holds the record of becoming one of the fastest growing exchanges upon launch, reaching over $1 billion in cumulative trading volume in just one month. Since then Helix has catapulted to new heights, attaining over $7 billion in cumulative trading volume across spot and perpetual markets

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Injective Labs right now.

Find jobs on Simplify and start your career today

đź’ˇ
We update Injective Labs's jobs every few hours, so check again soon! Browse all jobs →